Docetaxel combination a gem in NSCLC

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2005

Schlagwörter:	Lung Cancer Docetaxel Gemcitabine Vinorelbine Objective Response Rate

Anmerkung:	© Adis International Ltd 2005

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1486(2005), 1 vom: Mai, Seite 9-9
Übergeordnetes Werk:	volume:1486 ; year:2005 ; number:1 ; month:05 ; pages:9-9

Links:	Volltext

DOI / URN:	10.2165/00128413-200514860-00021

Katalog-ID:	SPR035216514

Internformat


LEADER	01000caa a22002652 4500
001	SPR035216514
003	DE-627
005	20230519073817.0
007	cr uuu---uuuuu
008	201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200514860-00021 \|2 doi
035			\|a (DE-627)SPR035216514
035			\|a (SPR)00128413-200514860-00021-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Docetaxel combination a gem in NSCLC
264		1	\|c 2005
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2005
650		4	\|a Lung Cancer \|7 (dpeaa)DE-He213
650		4	\|a Docetaxel \|7 (dpeaa)DE-He213
650		4	\|a Gemcitabine \|7 (dpeaa)DE-He213
650		4	\|a Vinorelbine \|7 (dpeaa)DE-He213
650		4	\|a Objective Response Rate \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1486(2005), 1 vom: Mai, Seite 9-9 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1486 \|g year:2005 \|g number:1 \|g month:05 \|g pages:9-9
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200514860-00021 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1486 \|j 2005 \|e 1 \|c 05 \|h 9-9

Indexfelder

matchkey_str	article:22306056:2005----::oeaecmiain
hierarchy_sort_str	2005
publishDate	2005
allfields	10.2165/00128413-200514860-00021 doi (DE-627)SPR035216514 (SPR)00128413-200514860-00021-e DE-627 ger DE-627 rakwb eng Docetaxel combination a gem in NSCLC 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1486(2005), 1 vom: Mai, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1486 year:2005 number:1 month:05 pages:9-9 https://dx.doi.org/10.2165/00128413-200514860-00021 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1486 2005 1 05 9-9
spelling	10.2165/00128413-200514860-00021 doi (DE-627)SPR035216514 (SPR)00128413-200514860-00021-e DE-627 ger DE-627 rakwb eng Docetaxel combination a gem in NSCLC 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1486(2005), 1 vom: Mai, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1486 year:2005 number:1 month:05 pages:9-9 https://dx.doi.org/10.2165/00128413-200514860-00021 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1486 2005 1 05 9-9
allfields_unstemmed	10.2165/00128413-200514860-00021 doi (DE-627)SPR035216514 (SPR)00128413-200514860-00021-e DE-627 ger DE-627 rakwb eng Docetaxel combination a gem in NSCLC 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1486(2005), 1 vom: Mai, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1486 year:2005 number:1 month:05 pages:9-9 https://dx.doi.org/10.2165/00128413-200514860-00021 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1486 2005 1 05 9-9
allfieldsGer	10.2165/00128413-200514860-00021 doi (DE-627)SPR035216514 (SPR)00128413-200514860-00021-e DE-627 ger DE-627 rakwb eng Docetaxel combination a gem in NSCLC 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1486(2005), 1 vom: Mai, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1486 year:2005 number:1 month:05 pages:9-9 https://dx.doi.org/10.2165/00128413-200514860-00021 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1486 2005 1 05 9-9
allfieldsSound	10.2165/00128413-200514860-00021 doi (DE-627)SPR035216514 (SPR)00128413-200514860-00021-e DE-627 ger DE-627 rakwb eng Docetaxel combination a gem in NSCLC 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1486(2005), 1 vom: Mai, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1486 year:2005 number:1 month:05 pages:9-9 https://dx.doi.org/10.2165/00128413-200514860-00021 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1486 2005 1 05 9-9
language	English
source	Enthalten in Inpharma weekly 1486(2005), 1 vom: Mai, Seite 9-9 volume:1486 year:2005 number:1 month:05 pages:9-9
sourceStr	Enthalten in Inpharma weekly 1486(2005), 1 vom: Mai, Seite 9-9 volume:1486 year:2005 number:1 month:05 pages:9-9
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Lung Cancer Docetaxel Gemcitabine Vinorelbine Objective Response Rate
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2005-05-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035216514
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035216514</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073817.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514860-00021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035216514</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514860-00021-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Docetaxel combination a gem in NSCLC</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Docetaxel</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gemcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vinorelbine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Objective Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1486(2005), 1 vom: Mai, Seite 9-9</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1486</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514860-00021</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1486</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-9</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Docetaxel combination a gem in NSCLC Lung Cancer (dpeaa)DE-He213 Docetaxel (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Vinorelbine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213
topic	misc Lung Cancer misc Docetaxel misc Gemcitabine misc Vinorelbine misc Objective Response Rate
spellingShingle	misc Lung Cancer misc Docetaxel misc Gemcitabine misc Vinorelbine misc Objective Response Rate Docetaxel combination a gem in NSCLC
topic_unstemmed	misc Lung Cancer misc Docetaxel misc Gemcitabine misc Vinorelbine misc Objective Response Rate
topic_browse	misc Lung Cancer misc Docetaxel misc Gemcitabine misc Vinorelbine misc Objective Response Rate
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Docetaxel combination a gem in NSCLC
ctrlnum	(DE-627)SPR035216514 (SPR)00128413-200514860-00021-e
title_full	Docetaxel combination a gem in NSCLC
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2005
contenttype_str_mv	txt
container_start_page	9
container_volume	1486
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200514860-00021
title_sort	docetaxel combination a gem in nsclc
title_auth	Docetaxel combination a gem in NSCLC
abstract	© Adis International Ltd 2005
abstractGer	© Adis International Ltd 2005
abstract_unstemmed	© Adis International Ltd 2005
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Docetaxel combination a gem in NSCLC
url	https://dx.doi.org/10.2165/00128413-200514860-00021
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200514860-00021
up_date	2024-07-03T13:53:52.533Z
_version_	1803566273039171585
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035216514</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073817.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514860-00021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035216514</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514860-00021-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Docetaxel combination a gem in NSCLC</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Docetaxel</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gemcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vinorelbine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Objective Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1486(2005), 1 vom: Mai, Seite 9-9</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1486</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514860-00021</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1486</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-9</subfield></datafield></record></collection>
score	7.3978424

Nicht das Richtige dabei?

Schreiben Sie uns!

Docetaxel combination a gem in NSCLC

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?